EGFR and colorectal carcinoma: Together with our findings that resistance to cetuximab-based chemotherapy is associated with the enrichment of M2 macrophage-related signals, we assume that EGFR inhibition may be no longer capable of promoting polarization to M1 nor suppressing M2 TAM-related features in the CRC microenvironment developing resistance to cetuximab-based treatments.